Clinical trial
Effect of Heart-Protecting Musk Pill on Diabetic Microangiopaemia in Type 2 Diabetes Patients
NCT05095922 is registered in ClinicalTrials.gov with Affiliated Hospital of Nantong University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effect of Heart-Protecting Musk Pill on Diabetic Microangiopaemia in Type 2 Diabetes Patients
- Lead sponsor
- Affiliated Hospital of Nantong University
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- March 28, 2023
- Completion date
- May 30, 2024
- Enrollment
- 40 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.